Form D · Other
Temple Turmeric, Inc.
New York, NY · CIK 0001626622
Offering snapshot reported Apr 23, 2018 · SEC filing
- Reported sold
- $2.25M Offering amount: $2.25M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 3, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 23, 2018 | Initial | $2,250,000 | No comparison | 1 | SEC filing |
| Dec 1, 2014 | Initial | $3,241,608 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-310771
Source: Form D, filed Apr 23, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carole Buyers | Director |
| Vance Fisher | Executive |
| Greg Fleishman | Director |
| Ian Knowles | Director, Executive |
| Sundip Murthy | Director |
| Duane Primozich | Director |
| Timothy Quick | Director |
| Tim Quick | Director |
| Ekta Sharma | Director |
| Jesal Sheth | Executive |
| Daniel Sullian | Director, Executive |
| Daniel Sullivan | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
48 Wall Street Suite 1100
New York, NY, 10005
New York, NY, 10005